Please assess the completion status of the following clinical trial:

Trial Title: Effect of Paracetamol, Dexketoprofen Trometamol, Lidocaine Spray, Pethidine and Diclofenac Sodium Application for Pain Relief During Fractional Curettage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* multiparous participants~* abnormal uterine bleeding~* postmenopausal bleeding~* myoma uteri causing menometrorrhagia~* cervical polyp~* tamoxifen treatment for breast cancer~* adnexial mass~Exclusion Criteria:~* abortions~* pregnancy~* primiparity~* diabetes mellitus~* tendency to bleed such as thrombocytopenia~* factor deficiency~* functional disorders of platelets

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Control group (Type: NO_INTERVENTION): Control group
- Pain reliever (Type: ACTIVE_COMPARATOR): 1000 mg paracetamol (Parol 1 g Atabay ilaç Turkey)
- Dexketoprofen trometamol (Type: ACTIVE_COMPARATOR): 25 mg oral Dexofen Atabay ilaç Turkey
- Lidocaine spray (Type: ACTIVE_COMPARATOR): 2 puff on cervical mucosa (Xylocain Pump 100 Mg 50 Ml Sprey Astra Zeneca)
- pethidine (Type: ACTIVE_COMPARATOR): Aldolan 100 mg Liba Laboratuarı İstanbul Turkey
- diclofenac sodium (Type: ACTIVE_COMPARATOR): Dicloron amp 75 mg Deva İlaç Levent İstanbul/Turkey

Based on this trial design, predict the completion outcome and termination type (if applicable).